Capstone Insider Trades
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Capstone insider activity
Over the last 12 months, Capstone insiders reported 15 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows FELDMAN FREDRIC J (Director) reporting a transaction in 105,124 shares on Aug 7, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CAPS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CAPS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 7, 2026 | Strout Gordon Lewis JrDirector | Award | 357,810 | — | Form 4 |
| Aug 7, 2026 | TOPOREK MICHAELDirector | Award | 1,094,647 | — | Form 4 |
| Aug 7, 2026 | HOWSE ELWOOD DDirector | Award | 105,124 | — | Form 4 |
| Aug 7, 2026 | SCHULTZ EDWARD CHRISTOPHERChief Financial Officer | Award | 310,310 | — | Form 4 |
| Aug 7, 2026 | Grotke Kevin AllanPresident & CEO of TotalStone | Award | 515,495 | — | Form 4 |
| Aug 7, 2026 | Lipman Matthew E.Chief Executive Officer | Award | 1,094,648 | — | Form 4 |
| Aug 7, 2026 | HOLLIMAN JOHN M IIIDirector | Award | 305,248 | — | Form 4 |
| Aug 7, 2026 | FELDMAN FREDRIC JDirector | Award | 105,124 | — | Form 4 |
| Mar 30, 2026 | SCHULTZ EDWARD CHRISTOPHERChief Financial Officer | Award | 190,000 | — | Form 4 |
| Mar 30, 2026 | Lipman Matthew E.Chief Executive Officer | Award | 356,250 | — | Form 4 |
| Mar 30, 2026 | TOPOREK MICHAELDirector | Award | 356,250 | — | Form 4 |
| Mar 30, 2026 | Strout Gordon Lewis JrDirector | Award | 142,500 | — | Form 4 |
| Mar 30, 2026 | HOWSE ELWOOD DDirector | Award | 95,000 | — | Form 4 |
| Mar 30, 2026 | HOLLIMAN JOHN M IIIDirector | Award | 95,000 | — | Form 4 |
| Mar 30, 2026 | FELDMAN FREDRIC JDirector | Award | 95,000 | — | Form 4 |
| Mar 7, 2025 | Lipman Matthew E.Chief Executive Officer | Buy | 41,750 | $167.00K | Form 4 |
| Mar 7, 2025 | TOPOREK MICHAELDirector | Buy | 41,750 | $167.00K | Form 4 |
| Mar 7, 2025 | Strout Gordon Lewis JrDirector | Buy | 41,500 | $166.00K | Form 4 |
| Mar 7, 2025 | Strout Gordon Lewis JrDirector | other | 822,128 | — | Form 4 |
| Dec 21, 2018 | SUBIN NEIL S10% Owner | Buy | 103,000 | $5.36K | Form 4 |
| Dec 21, 2018 | SUBIN NEIL S10% Owner | Sale | 206,000 | $10.71K | Form 4 |
| Oct 5, 2017 | MILLER LLOYD I III10% Owner | Sale | 100,000 | $6.00K | Form 4 |
| Jul 14, 2017 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BIOTECHNOLOGY VALUE FUND II LP & BVF INVESTMENTS LLC & BVF INC/IL & LAMPERT MARK NSee Explanation of Responses | Sale | 105,713 | $6.34K | Form 4 |
| Jul 14, 2017 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BIOTECHNOLOGY VALUE FUND II LP & BVF INVESTMENTS LLC & BVF INC/IL & LAMPERT MARK NSee Explanation of Responses | Sale | 242,236 | $14.53K | Form 4 |
| Jul 14, 2017 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BIOTECHNOLOGY VALUE FUND II LP & BVF INVESTMENTS LLC & BVF INC/IL & LAMPERT MARK NSee Explanation of Responses | Sale | 3,993,637 | $239.62K | Form 4 |
| Jan 4, 2017 | TAEGER LESLIE MSVP Chief Financial Officer | Buy | 50,000 | $3.50K | Form 4 |
| Dec 16, 2016 | MILLER LLOYD I III10% Owner | Sale | 38,967 | $1.56K | Form 4 |
| Dec 15, 2016 | MILLER LLOYD I III10% Owner | Sale | 20,000 | $800 | Form 4 |
| Aug 12, 2016 | MILLER LLOYD I III10% Owner | Sale | 16,000 | $880 | Form 4 |
| Aug 1, 2016 | MILLER LLOYD I III10% Owner | Sale | 80,000 | $4.86K | Form 4 |
| Jun 8, 2016 | MILLER LLOYD I III10% Owner | Sale | 14,000 | $1.12K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4